GO:0008299 isoprenoid biosynthetic process: Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0008299 (isoprenoid biosynthetic process) describes the chemical reactions and pathways that produce isoprene or compounds containing linked isoprene residues, collectively called isoprenoids.
• Two major routes generate isoprenoid precursors: the mevalonate (MVA) pathway in the cytosol and the methylerythritol phosphate (MEP) pathway in plastids, and their contributions can be dissected experimentally.
• Isoprenoids include sterols, prenyl groups, dolichols, ubiquinone, heme A, and thousands of plant and microbial natural products, making the pathway central to cell physiology.
• Prenylation of proteins such as RAS and APOE-dependent prenylome changes link isoprenoid biosynthesis to cancer, neurodegeneration, and metabolic disease.
• The pathway is a validated therapeutic target in multiple myeloma and a focus of metabolic engineering in cyanobacteria and plants.
• CRISPR knockout, point-mutation, knock-in, and overexpression models enable causal testing of isoprenoid pathway genes and their disease relevance.
Description
Isoprenoids are the largest and most structurally diverse family of natural products, encompassing sterols, carotenoids, prenylated proteins, dolichols, ubiquinone, and many plant and microbial secondary metabolites. The Gene Ontology term GO:0008299, isoprenoid biosynthetic process, captures the chemical reactions and pathways that form isoprene (2-methylbuta-1,3-diene) or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues. This process is fundamental to membrane integrity, protein prenylation, electron transport, and hormone and secondary metabolite production across all domains of life. Research into isoprenoid biosynthesis has been accelerated by the recognition that two distinct routes supply the universal precursors isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP): the mevalonate (MVA) pathway and the methylerythritol phosphate (MEP) pathway. Network analysis of these pathways has clarified how plants, microbes, and animals partition carbon into diverse isoprenoid end products. In parallel, isoprenoid biosynthesis has emerged as a therapeutic vulnerability in cancer, particularly multiple myeloma, and as a target for metabolic engineering in cyanobacteria and plants. Because isoprenoids influence protein localization, cell signaling, and membrane architecture, precise experimental models are needed to determine which genes are causally involved in specific isoprenoid-dependent phenotypes. This article summarizes the definition, mechanism, key genes, regulation, disease links, and research methods for GO:0008299, with an emphasis on CRISPR-based approaches for functional validation.
isoprenoid biosynthetic process At A Glance
| GO ID | GO:0008299 |
|---|---|
| GO term | isoprenoid biosynthetic process |
| Ontology | biological_process |
| Synonym | isoprenoid anabolism; isoprenoid biosynthesis; isoprenoid formation; isoprenoid synthesis; polyisoprenoid anabolism; polyisoprenoid biosynthesis; polyisoprenoid biosynthetic process; polyisoprenoid formation; polyisoprenoid synthesis; polyterpene biosynthesis; polyterpene biosynthetic process |
| Major function | Production of isoprene and isoprene-derived compounds, including sterols, prenyl groups, dolichols, ubiquinone, and terpenoids |
| Key precursor | Isopentenyl diphosphate (IPP) and dimethylallyl diphosphate (DMAPP) |
| Major routes | Mevalonate (MVA) pathway and methylerythritol phosphate (MEP) pathway |
| Representative products | Cholesterol, carotenoids, prenylated proteins, ubiquinone, dolichol |
What Is GO:0008299?
GO:0008299 (isoprenoid biosynthetic process) is defined as the chemical reactions and pathways resulting in the formation of an isoprenoid compound, isoprene (2-methylbuta-1,3-diene), or compounds containing or derived from linked isoprene (3-methyl-2-butenylene) residues. In practical terms, it covers the enzymatic steps that build the five-carbon isoprene units and assemble them into larger molecules such as sterols, prenyl chains, dolichols, and terpenoids.
Why Is isoprenoid biosynthetic process Important in Cell Biology?
Isoprenoid biosynthesis is essential because it supplies the building blocks for sterols, prenylated proteins, ubiquinone, dolichols, and a vast array of secondary metabolites that control membrane properties, signaling, and energy metabolism. Dysregulation of this pathway contributes to cancer, neurodegeneration, and metabolic disorders, and the pathway is a validated target in multiple myeloma. Understanding GO:0008299 therefore has broad implications for cell biology, pharmacology, and biotechnology.
• Provides sterols and prenyl groups required for membrane integrity and protein localization.
• Supports protein prenylation of RAS and other GTPases, linking the pathway to cancer signaling.
• Contributes to APOE allele-specific prenylome differences relevant to Alzheimer disease biology.
• Is a therapeutic target in multiple myeloma, where pathway inhibition impairs tumor growth.
• Enables production of carotenoids, ubiquinone, and dolichols for cellular antioxidant and electron transport functions.
• Underpins plant hormone and secondary metabolite biosynthesis with agricultural and pharmaceutical value.
• Is engineered in cyanobacteria for sustainable production of isoprenoid-derived chemicals.
• Provides a model for dissecting MVA versus MEP pathway contributions using metabolic labeling and inhibitors.
• Is relevant to non-canonical plant metabolism and metabolic network plasticity.
• Offers opportunities for programmable meroterpene synthesis through pathway engineering.
What Happens During isoprenoid biosynthetic process?
Acetyl-CoA to mevalonate (MVA pathway)
In simple terms: The cell first builds a small molecule called mevalonate from acetyl-CoA, which is the starting point for many isoprenoids.
In the mevalonate pathway, acetyl-CoA is converted through a series of enzymatic steps to mevalonate, which is then phosphorylated and decarboxylated to yield IPP and DMAPP. This route operates in the cytosol of animals and in the cytosol/ER of plants, and it supplies precursors for sterols, prenylated proteins, and dolichols. Network analyses have shown that MVA pathway flux is tightly coordinated with downstream demand for sterols and non-sterol isoprenoids.
Pyruvate and glyceraldehyde-3-phosphate to MEP (MEP pathway)
In simple terms: Plants and many bacteria use a different route that starts with pyruvate and a sugar phosphate to make the same five-carbon building blocks.
The methylerythritol phosphate (MEP) pathway condenses pyruvate and glyceraldehyde-3-phosphate to form 1-deoxy-D-xylulose 5-phosphate, which is converted to MEP and then to IPP and DMAPP. This pathway is localized to plastids in plants and is the source of isoprenoids for photosynthesis-related pigments, hormones, and plastidial terpenoids. Experimental toolboxes using labeled precursors and inhibitors allow researchers to assess the relative contributions of MVA and MEP pathways to specific end products.
IPP and DMAPP interconversion and prenyl chain elongation
In simple terms: The five-carbon units are shuffled and joined together to make longer chains that become sterols, carotenoids, and other isoprenoids.
IPP and DMAPP are interconverted by IPP isomerase, and prenyltransferases such as farnesyl diphosphate synthase and geranylgeranyl diphosphate synthase sequentially condense these units to form geranyl, farnesyl, and geranylgeranyl diphosphates. These prenyl diphosphates serve as substrates for sterol biosynthesis, protein prenylation, ubiquinone, dolichol, and heme A formation. The balance between different prenyl chain lengths determines the fate of the pathway toward sterol versus non-sterol products.
Terpenoid and meroterpene diversification
In simple terms: Enzymes called terpene synthases and modifying enzymes turn the basic prenyl chains into thousands of different natural products.
Terpene synthases and downstream modifying enzymes convert prenyl diphosphates into monoterpenes, sesquiterpenes, diterpenes, triterpenes, and meroterpenes. Programmable meroterpene synthesis has been demonstrated by engineering pathway enzymes to produce novel hybrid molecules. In plants, non-canonical metabolic routes further expand isoprenoid diversity, including alternative branch points and recycling pathways.
Protein prenylation and isoprenoid-dependent signaling
In simple terms: Some isoprenoids are attached to proteins, which helps those proteins stick to membranes and signal properly.
Farnesyl and geranylgeranyl groups are transferred to cysteine residues of target proteins by farnesyltransferase and geranylgeranyltransferases, a process called protein prenylation. Prenylation is required for the membrane localization and function of RAS, Rho, and other GTPases, and it links isoprenoid biosynthesis to cell proliferation and cancer. Metabolic labeling with isoprenoid probes has revealed APOE allele-specific differences in the prenylome, connecting the pathway to neurodegeneration.
Key Genes Involved in GO:0008299 isoprenoid biosynthetic process
The following genes and enzymes represent core components of the isoprenoid biosynthetic process across the MVA and MEP pathways, prenyltransferases, and downstream terpenoid enzymes.
| Gene | Major Role | Research Relevance |
|---|---|---|
| HMGCR | Rate-limiting enzyme of the MVA pathway converting HMG-CoA to mevalonate | Target of statins; knockout and point-mutation models for cholesterol and prenylation studies |
| MVK | Mevalonate kinase phosphorylates mevalonate in the MVA pathway | Mutations cause mevalonate kinase deficiency; relevant to autoinflammatory disease models |
| PMVK | Phosphomevalonate kinase in the MVA pathway | Enables dissection of MVA flux and intermediate accumulation |
| MVD | Mevalonate diphosphate decarboxylase produces IPP | Key node for metabolic labeling and flux analysis |
| IDI1 | Isopentenyl diphosphate isomerase interconverts IPP and DMAPP | Determines precursor balance for sterol and non-sterol isoprenoids |
| FDPS | Farnesyl diphosphate synthase generates FPP for sterols and prenylation | Target for cancer and bone disease; knockout affects RAS prenylation |
| GGPS1 | Geranylgeranyl diphosphate synthase produces GGPP | Required for geranylgeranylation of Rho GTPases |
| DXS | 1-deoxy-D-xylulose 5-phosphate synthase, first MEP pathway enzyme | Rate-limiting step in plastidial isoprenoid biosynthesis |
| DXR | 1-deoxy-D-xylulose 5-phosphate reductoisomerase in MEP pathway | Target of fosmidomycin; used to assess MEP contribution |
| MCT | 2-C-methyl-D-erythritol 4-phosphate cytidylyltransferase in MEP pathway | Essential for plastidial isoprenoid supply |
| CMK | 4-diphosphocytidyl-2-C-methyl-D-erythritol kinase in MEP pathway | Supports IPP/DMAPP production in plastids |
| MCS | 2-C-methyl-D-erythritol 2,4-cyclodiphosphate synthase in MEP pathway | Component of the MEP route for isoprenoid precursors |
| HDS | 4-hydroxy-3-methylbut-2-enyl diphosphate synthase in MEP pathway | Generates HMBPP intermediate |
| HDR | 4-hydroxy-3-methylbut-2-enyl diphosphate reductase produces IPP/DMAPP | Final step of MEP pathway; knockout affects plastidial isoprenoids |
| FNTA | Farnesyltransferase alpha subunit for protein prenylation | Required for RAS and nuclear lamina protein prenylation |
| FNTB | Farnesyltransferase beta subunit for protein prenylation | Target for cancer therapeutics |
| PGGT1B | Geranylgeranyltransferase type I beta subunit | Mediates geranylgeranylation of Rho and Rac |
| RABGGTA | Rab geranylgeranyltransferase alpha subunit | Prenylation of Rab GTPases for vesicle trafficking |
How Is isoprenoid biosynthetic process Regulated?
Isoprenoid biosynthesis is regulated at multiple levels, including transcriptional control of MVA and MEP pathway genes, feedback inhibition by sterol intermediates, and post-translational regulation of rate-limiting enzymes such as HMGCR. In plants, network analysis has revealed coordinated expression of MVA and MEP genes in response to developmental and environmental cues. Protein prenylation and prenylome composition are also regulated by the availability of prenyl diphosphates and by the activity of prenyltransferases. In cancer cells, oncogenic signaling can increase flux through the MVA pathway to support proliferation, making it a therapeutic target.
isoprenoid biosynthetic process and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| HMGCR | Cholesterol metabolism and cancer cell proliferation | Knockout and point-mutation cell lines; statin response assays |
| MVK | Mevalonate kinase deficiency and autoinflammation | Point-mutation knock-in models; cytokine profiling |
| FDPS | Multiple myeloma and prenylation-dependent signaling | Knockout and overexpression in myeloma cell lines |
| APOE | Alzheimer disease and prenylome alterations | APOE allele knock-in models with isoprenoid probes |
| FNTB | RAS-driven cancers | Knockout and point-mutation for prenylation inhibition studies |
Isoprenoid biosynthesis in multiple myeloma
Multiple myeloma cells depend on isoprenoid biosynthesis for survival and proliferation, and targeting the pathway with statins or prenyltransferase inhibitors impairs tumor growth. This dependency is linked to the need for prenylated GTPases such as RAS and Rho, which require farnesyl or geranylgeranyl groups for membrane localization and signaling. Experimental models using knockout or point-mutation of FDPS, FNTA, or FNTB can test causal roles in myeloma cell fitness.
APOE allele-specific prenylome in neurodegeneration
In vivo metabolic labeling with an isoprenoid probe has revealed APOE allele-specific differences in the prenylome, suggesting that isoprenoid biosynthesis and protein prenylation contribute to Alzheimer disease risk. These findings link GO:0008299 to neurodegeneration through altered prenylation of proteins involved in lipid transport and neuronal function. Knock-in models carrying APOE alleles can be used to dissect how isoprenoid flux modifies disease phenotypes.
Mevalonate kinase deficiency and autoinflammation
Mutations in MVK cause mevalonate kinase deficiency, an autoinflammatory disorder characterized by recurrent fever and elevated inflammatory cytokines. This condition demonstrates that disrupted isoprenoid biosynthesis can trigger innate immune activation, likely through reduced prenylation of small GTPases. Point-mutation and knockout cell models of MVK are valuable for studying the link between isoprenoid flux and inflammation.
Isoprenoid pathway in cancer metabolism and therapy
Beyond multiple myeloma, the MVA pathway is upregulated in many cancers to support sterol synthesis and protein prenylation, and inhibitors of HMGCR or prenyltransferases have shown anti-tumor effects. The pathway also intersects with non-canonical metabolic routes that may provide resistance mechanisms. CRISPR knockout screens targeting isoprenoid enzymes can identify synthetic lethal interactions with existing therapies.
From isoprenoid biosynthetic process-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Is HMGCR required for cancer cell proliferation? | CRISPR knockout of HMGCR in cancer cell lines |
| Does a specific MVK mutation cause autoinflammation? | Point-mutation knock-in of MVK in immune cells |
| How does APOE genotype affect the prenylome? | APOE allele knock-in with isoprenoid metabolic labeling |
| Can FDPS overexpression drive prenylation-dependent growth? | Overexpression of FDPS in myeloma cells |
| What is the role of DXR in plastidial isoprenoid flux? | Knockout or knockdown of DXR in plant or algal models |
| Can engineered terpene synthases produce novel meroterpenes? | Overexpression of synthetic pathway enzymes in microbial hosts |
How to Study the isoprenoid biosynthetic process Process
| Method | What It Measures | Typical Application |
|---|---|---|
| 13C metabolic flux analysis | Carbon flux through MVA and MEP pathways | Quantifying pathway contributions in cells and plants |
| Isoprenoid probe labeling | Prenylated protein profiles | APOE allele-specific prenylome analysis |
| RNA-seq and co-expression networks | Transcript levels and pathway coordination | Identifying regulators of isoprenoid biosynthesis |
| Proteomics with click chemistry | Global prenylation status | Detecting RAS and Rho prenylation |
| CRISPR knockout screens | Gene essentiality and synthetic lethality | Cancer dependency mapping in myeloma |
| Enzyme activity assays | Catalytic activity of pathway enzymes | Characterizing HMGCR, FDPS, or DXR variants |
| Metabolomics (LC-MS/GC-MS) | Isoprenoid intermediate and end-product levels | Assessing pathway flux and drug effects |
| Reporter gene assays | Pathway-responsive transcription | Screening for pathway modulators |
Metabolic labeling and flux analysis
Isotope-labeled precursors such as 13C-acetate or 13C-pyruvate can be used to trace carbon flux through the MVA and MEP pathways and quantify isoprenoid end products. In vivo metabolic labeling with isoprenoid probes enables detection of prenylated proteins and allele-specific prenylome differences. These methods are essential for determining pathway contributions in different cell types.
Transcriptomics and network analysis
RNA-seq and co-expression network analysis reveal coordinated regulation of MVA and MEP pathway genes across conditions and tissues. Such analyses can identify candidate regulators and non-canonical pathway branches. Integrating transcriptomics with metabolomics provides a systems-level view of isoprenoid biosynthesis.
Proteomics and prenylation assays
Proteomic workflows using click chemistry or biotinylated isoprenoid probes allow global profiling of prenylated proteins. Western blotting with prenylation-specific antibodies can validate individual targets such as RAS or Rho. These approaches link isoprenoid biosynthesis to protein localization and signaling.
Genetic screens and CRISPR libraries
CRISPR knockout libraries targeting isoprenoid pathway genes can identify essential nodes and synthetic lethal interactions in cancer cells. Pooled screens combined with metabolic profiling reveal genes required for specific isoprenoid-dependent phenotypes. Such screens are complemented by overexpression or point-mutation models to test causality.
How CRISPR Can Be Used to Study GO:0008299 isoprenoid biosynthetic process
Knockout
CRISPR knockout of isoprenoid pathway genes such as HMGCR, FDPS, or MVK can reveal essential functions in cell proliferation, sterol synthesis, and protein prenylation. Knockout models are particularly useful for testing whether a specific enzyme is required for cancer cell survival or for inflammatory responses. These models can be combined with metabolic rescue experiments to confirm on-target effects.
Point Mutation
Point-mutation knock-in models can replicate disease-associated variants in genes such as MVK or HMGCR, allowing precise interrogation of catalytic and regulatory domains. Such models are valuable for studying mevalonate kinase deficiency and statin resistance. They also enable structure-function analysis of prenyltransferases.
Knock-in
Knock-in of reporter tags or epitope tags into endogenous isoprenoid genes facilitates tracking of protein localization and interactions. Allele-specific knock-in of APOE variants can be used to study prenylome differences in a controlled genetic background. Tagged knock-in of pathway enzymes supports proteomic and imaging studies.
Overexpression
Overexpression of rate-limiting enzymes such as DXS or FDPS can increase flux through the isoprenoid pathway and boost production of downstream products. In metabolic engineering, overexpression of terpene synthases and pathway enzymes enables programmable meroterpene synthesis. Overexpression models also help test gain-of-function hypotheses in cancer and neurodegeneration.
How EDITGENE Supports isoprenoid biosynthetic process Research
Researchers studying isoprenoid biosynthetic process-related genes often need to determine whether a candidate gene is causally involved in a specific phenotype, such as cancer cell growth, prenylation-dependent signaling, or metabolic flux. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in, and overexpression of isoprenoid pathway genes, along with library screening and bioinformatics support to accelerate functional validation.
Contact EDITGENE today to design your custom CRISPR model for isoprenoid biosynthetic process research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| FDPS Knockout HEK293 Cell Line | EDJ-KQ1488 | Human | 2224 | Details Get a Quote |
| HMGCS2 Knockout HEK293 Cell Line | EDJ-KQ2610 | Human | 3158 | Details Get a Quote |
| IDI1 Knockout HEK293 Cell Line | EDJ-KQ4965 | Human | 3422 | Details Get a Quote |
| PDSS1 Knockout HEK293 Cell Line | EDJ-KQ8081 | Human | 23590 | Details Get a Quote |
| IDI2 Knockout HEK293 Cell Line | EDJ-KQ10775 | Human | 91734 | Details Get a Quote |
| CRPPA Knockout HEK293 Cell Line | EDJ-KQ13005 | Human | 729920 | Details Get a Quote |
| PDSS2 Knockout HEK293 Cell Line | EDJ-KQ14720 | Human | 57107 | Details Get a Quote |
| PDSS1 Knockout A-549 Cell Line | EDJ-KQ33921 | Human | 23590 | Details Get a Quote |
| PDSS1 Knockout HCT 116 Cell Line | EDJ-KQ33922 | Human | 23590 | Details Get a Quote |
| PDSS1 Knockout HeLa Cell Line | EDJ-KQ33923 | Human | 23590 | Details Get a Quote |
| CRPPA Knockout HCT 116 Cell Line | EDJ-KQ41020 | Human | 729920 | Details Get a Quote |
| FDPS Knockout A-549 Cell Line | EDJ-KQ22390 | Human | 2224 | Details Get a Quote |
| FDPS Knockout HCT 116 Cell Line | EDJ-KQ22391 | Human | 2224 | Details Get a Quote |
| FDPS Knockout HeLa Cell Line | EDJ-KQ22392 | Human | 2224 | Details Get a Quote |
| IDI1 Knockout A-549 Cell Line | EDJ-KQ27842 | Human | 3422 | Details Get a Quote |
Displaying Records 1 To 15 Of 30 Records
Frequently Asked Questions About isoprenoid biosynthetic process
What is isoprenoid biosynthetic process (GO:0008299)?
GO:0008299 describes the chemical reactions and pathways that form isoprene or compounds containing linked isoprene residues, including sterols, prenyl groups, and terpenoids.
What genes are involved in isoprenoid biosynthetic process?
Key genes include HMGCR, MVK, PMVK, MVD, IDI1, FDPS, GGPS1, DXS, DXR, MCT, CMK, MCS, HDS, HDR, FNTA, FNTB, PGGT1B, and RABGGTA.
What are the two main pathways for isoprenoid biosynthesis?
The mevalonate (MVA) pathway and the methylerythritol phosphate (MEP) pathway, which operate in different cellular compartments and organisms.
Why is isoprenoid biosynthesis important in cancer?
It supports sterol synthesis and protein prenylation required for cancer cell proliferation, and it is a therapeutic target in multiple myeloma.
How is isoprenoid biosynthesis regulated?
It is regulated by transcriptional control, feedback inhibition by sterol intermediates, and post-translational regulation of rate-limiting enzymes such as HMGCR.
What diseases are linked to isoprenoid biosynthesis defects?
Mevalonate kinase deficiency, cancer, and neurodegeneration have been linked to altered isoprenoid biosynthesis and prenylation.
How can CRISPR be used to study isoprenoid biosynthesis?
CRISPR knockout, point mutation, knock-in, and overexpression models allow causal testing of pathway genes in disease and metabolic contexts.
What methods measure isoprenoid pathway flux?
13C metabolic flux analysis, metabolic labeling with isoprenoid probes, and metabolomics are commonly used.
What is protein prenylation and how does it relate to isoprenoids?
Protein prenylation is the attachment of farnesyl or geranylgeranyl groups to proteins, which requires isoprenoid precursors and affects membrane localization and signaling.
Can isoprenoid biosynthesis be engineered for biotechnology?
Yes, cyanobacteria and microbial hosts have been engineered to produce isoprenoid-derived chemicals and meroterpenes.
Conclusion
GO:0008299 (isoprenoid biosynthetic process) is a central metabolic pathway that supplies sterols, prenyl groups, and thousands of natural products essential for cell function and organismal physiology. Its dysregulation is implicated in cancer, autoinflammatory disease, and neurodegeneration, making it a high-value target for therapeutic and biotechnological applications. CRISPR-based cell models provide a powerful means to dissect the causal roles of individual isoprenoid pathway genes and to accelerate the development of targeted interventions.
References
- 1. Vranová E et al.. 2013. Network analysis of the MVA and MEP pathways for isoprenoid synthesis.. Annu Rev Plant Biol 64:665-700 PMID: 23451776
- 2. Haney SL et al.. 2022. Targeting the Isoprenoid Biosynthetic Pathway in Multiple Myeloma.. Int J Mol Sci 24(1) PMID: 36613550
- 3. Lipko A et al.. 2016. Isoprenoid generating systems in plants - A handy toolbox how to assess contribution of the mevalonate and methylerythritol phosphate pathways to the biosynthetic process.. Prog Lipid Res 63:70-92 PMID: 27133788
- 4. McTaggart SJ. 2006. Isoprenylated proteins.. Cell Mol Life Sci 63(3):255-67 PMID: 16378247
- 5. Shen X et al.. 2020. Programmable meroterpene synthesis.. Nat Commun 11(1):508 PMID: 31980637
- 6. Sweetlove LJ et al.. 2025. Non-canonical plant metabolism.. Nat Plants 11(4):696-708 PMID: 40164785
- 7. Petre AM et al.. 2025. In Vivo Metabolic Labeling with an Isoprenoid Probe Reveals APOE Allele-Specific Differences in the Prenylome.. ACS Chem Biol 20(8):1951-1961 PMID: 40767769
- 8. Melis A et al.. 2024. Perspectives of cyanobacterial cell factories.. Photosynth Res 162(2-3):459-471 PMID: 37966575
